Soleo Health expands relationship with AscellaHealth
By HME News Staff
Updated Wed November 4, 2020
FRISCO, Texas - Soleo Health has been selected by AscellaHealth as a tier-one preferred provider for the care and management of its members requiring intravenous immunoglobin therapies (IVIG), as well as subcutaneous immunoglobin therapies (SCIG). Soleo Health is one of only two preferred providers of immunoglobin therapy for AscellaHealth, a national specialty pharmacy benefit manager, serving commercial, Medicare and Medicaid markets. AscellaHealth manages care for thousands of members with immunodeficiencies and autoimmune disorders and Soleo Health now provides clinical support to members in need of IVIG and SCIG therapies. Soleo Health brings to the table its Therapeutic Care Management Centers staffed with a specially trained, local and national interdisciplinary IG-focused team. Previously, in July, Soleo Health became one of four exclusive providers for AscellaHealth in the care and management of its hemophilia members.
Comments